{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:19:11Z","timestamp":1768004351499,"version":"3.49.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00109-013-1046-9","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T18:53:07Z","timestamp":1367347987000},"page":"705-713","source":"Crossref","is-referenced-by-count":44,"title":["The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease"],"prefix":"10.1007","volume":"91","author":[{"given":"Marta","family":"Amaral","sequence":"first","affiliation":[]},{"given":"Tiago F.","family":"Outeiro","sequence":"additional","affiliation":[]},{"given":"Nigel S.","family":"Scrutton","sequence":"additional","affiliation":[]},{"given":"Flaviano","family":"Giorgini","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,5,1]]},"reference":[{"issue":"6","key":"1046_CR1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2174\/187152710793237430","volume":"9","author":"MA Thevandavakkam","year":"2010","unstructured":"Thevandavakkam MA, Schwarcz R, Muchowski PJ, Giorgini F (2010) Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington\u2019s disease. CNS Neurol Disord Drug Targets 9(6):791\u2013800","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"15","key":"1046_CR2","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1158\/0008-5472.CAN-07-1872","volume":"67","author":"R Metz","year":"2007","unstructured":"Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC (2007) Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res 67(15):7082\u20137087","journal-title":"Cancer Res"},{"issue":"3","key":"1046_CR3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00018-009-0166-4","volume":"67","author":"Q Han","year":"2010","unstructured":"Han Q, Cai T, Tagle D, Li J (2010) Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Cellular and molecular life sciences : CMLS 67(3):353\u2013368","journal-title":"Cellular and molecular life sciences : CMLS"},{"issue":"7","key":"1046_CR4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13(7):465\u2013477","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"1046_CR5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/ars.2007.1672","volume":"10","author":"W Ying","year":"2008","unstructured":"Ying W (2008) NAD+\/NADH and NADP+\/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 10(2):179\u2013206","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"1046_CR6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1471-4906(03)00072-3","volume":"24","author":"U Grohmann","year":"2003","unstructured":"Grohmann U (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends in Immunology 24(5):242\u2013248","journal-title":"Trends in Immunology"},{"issue":"4","key":"1046_CR7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","volume":"196","author":"G Frumento","year":"2002","unstructured":"Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196(4):459\u2013468","journal-title":"J Exp Med"},{"key":"1046_CR8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2008.00610.x","volume":"222","author":"JB Katz","year":"2008","unstructured":"Katz JB, Muller AJ, Prendergast GC (2008) T-cell tolerance and tumoral immune escape. Immunol Rev 222:206\u2013221","journal-title":"Immunol Rev"},{"issue":"7","key":"1046_CR9","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1073\/pnas.1113873109","volume":"109","author":"L Pilotte","year":"2012","unstructured":"Pilotte L, Larrieu P, Stroobant V, Colau D, Dolusic E, Fr\u00e9d\u00e9rick R, De Plaen E, Uyttenhove C, Wouters J, Masereel B et al (2012) Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc Natl Acad Sci U S A 109(7):2497\u20132502","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1046_CR10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.coi.2006.01.002","volume":"18","author":"DH Munn","year":"2006","unstructured":"Munn DH (2006) Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. Curr Opin Immunol 18(2):220\u2013225","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"1046_CR11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","volume":"9","author":"C Uyttenhove","year":"2003","unstructured":"Uyttenhove C, Pilotte L, Th\u00e9ate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde B (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9(10):1269\u20131274","journal-title":"Nat Med"},{"issue":"46","key":"1046_CR12","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1073\/pnas.1014465107","volume":"107","author":"NT Nguyen","year":"2010","unstructured":"Nguyen NT, Kimura A, Nakahama T, Chinen I, Masuda K, Nohara K, Fujii-Kuriyama Y, Kishimoto T (2010) Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci U S A 107(46):19961\u201319966","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1046_CR13","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA (2010) An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 185(6):3190\u20133198","journal-title":"J Immunol"},{"issue":"3","key":"1046_CR14","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1021\/jm9014718","volume":"53","author":"UF R\u00f6hrig","year":"2010","unstructured":"R\u00f6hrig UF, Awad L, Grosdidier A, Larrieu P, Stroobant V, Colau D, Cerundolo V, Simpson AJ, Vogel P, Van den Eynde BJ et al (2010) Rational design of indoleamine 2,3-dioxygenase inhibitors. J Med Chem 53(3):1172\u20131189","journal-title":"J Med Chem"},{"issue":"23","key":"1046_CR15","doi-asserted-by":"crossref","first-page":"7364","DOI":"10.1021\/jm900518f","volume":"52","author":"EW Yue","year":"2009","unstructured":"Yue EW, Douty B, Wayland B, Bower M, Liu X, Leffet L, Wang Q, Bowman KJ, Hansbury MJ, Liu C et al (2009) Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model. J Med Chem 52(23):7364\u20137367","journal-title":"J Med Chem"},{"issue":"7368","key":"1046_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M et al (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478(7368):197\u2013203","journal-title":"Nature"},{"issue":"1","key":"1046_CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01262727","volume":"42","author":"IP Lapin","year":"1978","unstructured":"Lapin IP (1978) Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. J Neural Transm 42(1):37\u201343","journal-title":"J Neural Transm"},{"issue":"4","key":"1046_CR18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","volume":"72","author":"TW Stone","year":"1981","unstructured":"Stone TW, Perkins MN (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol 72(4):411\u2013412","journal-title":"Eur J Pharmacol"},{"issue":"4582","key":"1046_CR19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","volume":"219","author":"R Schwarcz","year":"1983","unstructured":"Schwarcz R, Whetsell WO Jr, Mangano RM (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219(4582):316\u2013318","journal-title":"Science"},{"issue":"8","key":"1046_CR20","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/sj.bjp.0702940","volume":"128","author":"WM Behan","year":"1999","unstructured":"Behan WM, McDonald M, Darlington LG, Stone TW (1999) Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharm 128(8):1754\u20131760","journal-title":"Br J Pharm"},{"issue":"10","key":"1046_CR21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00966592","volume":"16","author":"C Rios","year":"1991","unstructured":"Rios C, Santamaria A (1991) Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res 16(10):1139\u20131143","journal-title":"Neurochem Res"},{"key":"1046_CR22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0304-3940(89)90609-5","volume":"97","author":"WO Whetsell","year":"1989","unstructured":"Whetsell WO, Schwarcz R (1989) Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett 97:271\u2013275","journal-title":"Neurosci Lett"},{"issue":"7","key":"1046_CR23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1515\/CCLM.2003.129","volume":"41","author":"TW Stone","year":"2003","unstructured":"Stone TW, Mackay GM, Forrest CM, Clark CJ, Darlington LG (2003) Tryptophan metabolites and brain disorders. Clin Chem Lab Med 41(7):852\u2013859","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"1046_CR24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","volume":"247","author":"MN Perkins","year":"1982","unstructured":"Perkins MN, Stone TW (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Research 247(1):184\u2013187","journal-title":"Brain Research"},{"issue":"31","key":"1046_CR25","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","volume":"281","author":"J Wang","year":"2006","unstructured":"Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L (2006) Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281(31):22021\u201322028","journal-title":"J Biol Chem"},{"issue":"19","key":"1046_CR26","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","volume":"21","author":"C Hilmas","year":"2001","unstructured":"Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21(19):7463\u20137473","journal-title":"J Neurosci"},{"key":"1046_CR27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2005.07.004","volume":"197","author":"MT Sapko","year":"2006","unstructured":"Sapko MT, Guidetti P, Yu P, Tagle DA, Pellicciari R, Schwarcz R (2006) Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington\u2019s disease. Exp Neurol 197:31\u201340","journal-title":"Exp Neurol"},{"issue":"6","key":"1046_CR28","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR (1991) Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56(6):2007\u20132017","journal-title":"J Neurochem"},{"issue":"16","key":"1046_CR29","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.2174\/092986709789909602","volume":"16","author":"F Fulop","year":"2009","unstructured":"Fulop F, Szatmari I, Vamos E, Zadori D, Toldi J, Vecsei L (2009) Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives. Curr Med Chem 16(16):4828\u20134842","journal-title":"Curr Med Chem"},{"issue":"1\u20133","key":"1046_CR30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2011.05.069","volume":"667","author":"L Gell\u00e9rt","year":"2011","unstructured":"Gell\u00e9rt L, Fuzik J, G\u00f6bl\u00f6s A, S\u00e1rk\u00f6zi K, Marosi M, Kis Z, Farkas T, Szatm\u00e1ri I, F\u00fcl\u00f6p F, V\u00e9csei L et al (2011) Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia. Eur J Pharmacol 667(1\u20133):182\u2013187","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"1046_CR31","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.sbi.2008.09.009","volume":"18","author":"F Rossi","year":"2008","unstructured":"Rossi F, Schwarcz R, Rizzi M (2008) Curiosity to kill the KAT (kynurenine aminotransferase): structural insights into brain kynurenic acid synthesis. Curr Opin Struct Biol 18(6):748\u2013755","journal-title":"Curr Opin Struct Biol"},{"issue":"1\u20132","key":"1046_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2009.02.326","volume":"283","author":"E Vamos","year":"2009","unstructured":"Vamos E, Pardutz A, Klivenyi P, Toldi J, Vecsei L (2009) The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. J Neurol Sci 283(1\u20132):21\u201327","journal-title":"J Neurol Sci"},{"issue":"22","key":"1046_CR33","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.93.22.12553","volume":"93","author":"S Okuda","year":"1996","unstructured":"Okuda S, Nishiyama N, Saito H, Katsuki H (1996) Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc Natl Acad Sci U S A 93(22):12553\u201312558","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1046_CR34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","volume":"70","author":"S Okuda","year":"1998","unstructured":"Okuda S, Nishiyama N, Saito H, Katsuki H (1998) 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70(1):299\u2013307","journal-title":"J Neurochem"},{"issue":"4","key":"1046_CR35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","volume":"78","author":"GJ Guillemin","year":"2001","unstructured":"Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, Croitoru J, Brew BJ (2001) Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem 78(4):842\u2013853","journal-title":"J Neurochem"},{"issue":"4","key":"1046_CR36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/glia.10175","volume":"41","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ, Croitoru-Lamoury J, Dormont D, Armati PJ, Brew BJ (2003) Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia 41(4):371\u2013381","journal-title":"Glia"},{"key":"1046_CR37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(92)90749-W","volume":"144","author":"SJ Pearson","year":"1992","unstructured":"Pearson SJ, Reynolds GP (1992) Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington \u2019 s disease. Neurosci Lett 144:199\u2013201","journal-title":"Neurosci Lett"},{"issue":"9","key":"1046_CR38","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.42.9.1702","volume":"42","author":"T Ogawa","year":"1992","unstructured":"Ogawa T, Matson W, Beal M, Myers R, Bird E, Milbury P, Saso S (1992) Kynurenine pathway abnormalities in Parkinson\u2019s disease. Neurology 42(9):1702\u20131706","journal-title":"Neurology"},{"key":"1046_CR39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3940(95)11324-P","volume":"187","author":"A Sardar","year":"1995","unstructured":"Sardar A, Reynolds P (1995) Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-l-associated dementia. Neurosci Lett 187:9\u201312","journal-title":"Neurosci Lett"},{"issue":"11","key":"1046_CR40","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","volume":"11","author":"P Guidetti","year":"1999","unstructured":"Guidetti P, Schwarcz R (1999) 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. Eur J Neurosci 11(11):3857\u20133863","journal-title":"Eur J Neurosci"},{"key":"1046_CR41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuropharm.2012.03.009","volume":"66","author":"CS Copeland","year":"2013","unstructured":"Copeland CS, Neale SA, Salt TE (2013) Actions of xanthurenic acid, a putative endogenous group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus. Neuropharmacology 66:133\u2013142","journal-title":"Neuropharmacology"},{"issue":"5","key":"1046_CR42","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1124\/mol.111.074765","volume":"81","author":"F Fazio","year":"2012","unstructured":"Fazio F, Lionetto L, Molinaro G, Bertrand HO, Acher F, Ngomba RT, Notartomaso S, Curini M, Rosati O, Scarselli P et al (2012) Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors. Mol Pharmacol 81(5):643\u2013656","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1046_CR43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10(1):83\u201398","journal-title":"Lancet Neurol"},{"issue":"1","key":"1046_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S0033291799002871","volume":"31","author":"LW Ho","year":"2001","unstructured":"Ho LW, Carmichael J, Swartz J, Wyttenbach A, Rankin J, Rubinsztein DC (2001) The molecular biology of Huntington\u2019s disease. Psychol Med 31(1):3\u201314","journal-title":"Psychol Med"},{"issue":"3","key":"1046_CR45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","volume":"17","author":"P Guidetti","year":"2004","unstructured":"Guidetti P, Luthi-Carter RE, Augood SJ, Schwarcz R (2004) Neostriatal and cortical quinolinate levels are increased in early grade Huntington\u2019s disease. Neurobiol Dis 17(3):455\u2013461","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1046_CR46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","volume":"23","author":"P Guidetti","year":"2006","unstructured":"Guidetti P, Bates GP, Graham RK, Hayden MR, Leavitt BR, MacDonald ME, Slow EJ, Wheeler VC, Woodman B, Schwarcz R (2006) Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice. Neurobiol Dis 23(1):190\u2013197","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1046_CR47","first-page":"7","volume":"12","author":"F Giorgini","year":"2012","unstructured":"Giorgini F (2012) Targeting the kynurenine pathway in Huntington \u2019 s disease. ACNR 12(1):7\u20138","journal-title":"ACNR"},{"key":"1046_CR48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-510X(94)00280-2","volume":"130","author":"D Jauch","year":"1995","unstructured":"Jauch D, Urbaiiska EM, Guidetti P, Bird ED, Vonsattel JG, Whetsell W, Schwartz R (1995) Dysfunction of brain kynurenic acid metabolism in Huntington\u2019s disease: focus on kynurenine aminotransferases. J Neurol Sci 130:39\u201347","journal-title":"J Neurol Sci"},{"issue":"3","key":"1046_CR49","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","volume":"93","author":"N Stoy","year":"2005","unstructured":"Stoy N, Mackay GM, Forrest CM, Christofides J, Egerton M, Stone TW, Darlington LG (2005) Tryptophan metabolism and oxidative stress in patients with Huntington\u2019s disease. J Neurochem 93(3):611\u2013623","journal-title":"J Neurochem"},{"issue":"4","key":"1046_CR50","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/hmg\/ddp527","volume":"19","author":"G Mazarei","year":"2010","unstructured":"Mazarei G, Neal SJ, Becanovic K, Luthi-Carter R, Simpson EM, Leavitt BR (2010) Expression analysis of novel striatal-enriched genes in Huntington disease. Hum Mol Genet 19(4):609\u2013622","journal-title":"Hum Mol Genet"},{"issue":"11","key":"1046_CR51","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang C-E, Li H, Wang J, Rong J, Xu X, Mastroberardino PG, Greenamyre JT, Li X-J (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28(11):2783\u20132792","journal-title":"J Neurosci"},{"issue":"4","key":"1046_CR52","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1046\/j.1471-4159.1997.69041629.x","volume":"69","author":"YM Bordelon","year":"1997","unstructured":"Bordelon YM, Chesselet MF, Nelson D, Welsh F, Ereci\u0144ska M (1997) Energetic dysfunction in quinolinic acid-lesioned rat striatum. J Neurochem 69(4):1629\u20131639","journal-title":"J Neurochem"},{"issue":"8","key":"1046_CR53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","volume":"1","author":"TW Stone","year":"2002","unstructured":"Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1(8):609\u2013620","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1046_CR54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-291X(67)90123-4","volume":"26","author":"H Okamoto","year":"1967","unstructured":"Okamoto H, Yamamoto S, Nozaki M, Hayaishi O (1967) On the submitochondrial localization of L-kynurenine-3-hydroxylase. Biochem Biophys Res Commun 26(3):309\u2013314","journal-title":"Biochem Biophys Res Commun"},{"key":"1046_CR55","unstructured":"John R, Truscott W (2007) Eye lens proteins and cataracts. Protein misfolding, aggregation and conformational diseases. pp 435\u2013447"},{"issue":"6","key":"1046_CR56","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/bi051737+","volume":"45","author":"A Korlimbinis","year":"2006","unstructured":"Korlimbinis A, Hains PG, Truscott RJ, Aquilina JA (2006) 3-Hydroxykynurenine oxidizes alpha-crystallin: potential role in cataractogenesis. Biochemistry 45(6):1852\u20131860","journal-title":"Biochemistry"},{"issue":"12","key":"1046_CR57","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1074\/jbc.M708192200","volume":"283","author":"F Giorgini","year":"2008","unstructured":"Giorgini F, M\u00f6ller T, Kwan W, Zwilling D, Wacker JL, Hong S, Tsai LC, Cheah CS, Schwarcz R, Guidetti P et al (2008) Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment. J Biol Chem 283(12):7390\u20137400","journal-title":"J Biol Chem"},{"issue":"11","key":"1046_CR58","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","volume":"21","author":"S Campesan","year":"2011","unstructured":"Campesan S, Green EW, Breda C, Sathyasaikumar KV, Muchowski PJ, Schwarcz R, Kyriacou CP, Giorgini F (2011) The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington\u2019s disease. Curr Biol 21(11):961\u2013966","journal-title":"Curr Biol"},{"issue":"6","key":"1046_CR59","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1471-4159.2010.06675.x","volume":"113","author":"KV Sathyasaikumar","year":"2010","unstructured":"Sathyasaikumar KV, Stachowski EK, Amori L, Guidetti P, Muchowski PJ, Schwarcz R (2010) Dysfunctional kynurenine pathway metabolism in the R6\/2 mouse model of Huntington\u2019s disease. J Neurochem 113(6):1416\u20131425","journal-title":"J Neurochem"},{"issue":"5","key":"1046_CR60","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","volume":"9","author":"M Citron","year":"2010","unstructured":"Citron M (2010) Alzheimer\u2019s disease: strategies for disease modification. Nat Rev Drug Discov 9(5):387\u2013398","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"1046_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0006344","volume":"4","author":"A Rahman","year":"2009","unstructured":"Rahman A, Ting K, Cullen KM, Braidy N, Brew BJ, Guillemin GJ (2009) The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PLoS One 4(7):1\u201315","journal-title":"PLoS One"},{"issue":"18","key":"1046_CR62","first-page":"311","volume":"14","author":"GJ Guillemin","year":"2010","unstructured":"Guillemin GJ, Smythe GA, Veas LA, Takikawa O, Brew BJ (2010) Ab1-42 induces production of quinolinic acid by human macrophages and microglia. Neuroreport 14(18):311\u2013315","journal-title":"Neuroreport"},{"issue":"4","key":"1046_CR63","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","volume":"31","author":"GJ Guillemin","year":"2005","unstructured":"Guillemin GJ, Brew BJ, Noonan CE, Takikawa O, Cullen KM (2005) Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus. Neuropathol Appl Neurobiol 31(4):395\u2013404","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"1046_CR64","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuint.2006.08.012","volume":"50","author":"Z Hartai","year":"2007","unstructured":"Hartai Z, Juh\u00e1sz A, Riman\u00f3czy A, Jan\u00e1ky T, Donk\u00f3 T, Dux L, Penke B, T\u00f3th GK, Janka Z, K\u00e1lm\u00e1n J (2007) Decreased serum and red blood cell kynurenic acid levels in Alzheimer\u2019s disease. Neurochem Int 50(2):308\u2013313","journal-title":"Neurochem Int"},{"key":"1046_CR65","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","volume":"115","author":"MP Heyes","year":"1992","unstructured":"Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack M, Der M, Dilling L, Elia J, Kruesi MJ, Lackner A (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115:1249\u20131273","journal-title":"Brain"},{"issue":"2","key":"1046_CR66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","volume":"55","author":"E Gulaj","year":"2010","unstructured":"Gulaj E, Pawlak K, Bien B, Pawlak D (2010) Kynurenine and its metabolites in Alzheimer\u2019s disease patients. Adv Med Sci 55(2):204\u2013211","journal-title":"Adv Med Sci"},{"issue":"4","key":"1046_CR67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/174329210X12650506623645","volume":"15","author":"DJ Bonda","year":"2011","unstructured":"Bonda DJ, Mailankot M, Stone JG, Garrett MR, Castellani RJ, Siedlak SL, Zhu X, Perry G, Nagaraj RH, Smith MA (2011) Indoleamine 2,3-dioxygenase and 3OH-kynurenine modifications are found in the neuropathology of Alzheimer disease. Redox Rep 15(4):161\u2013168","journal-title":"Redox Rep"},{"issue":"2","key":"1046_CR68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s007020050149","volume":"106","author":"H Baran","year":"1999","unstructured":"Baran H, Jellinger K, Deecke L (1999) Kynurenine metabolism in Alzheimer\u2019s disease. J Neural Transm 106(2):165\u2013181","journal-title":"J Neural Transm"},{"issue":"5","key":"1046_CR69","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1542","volume":"37","author":"F Giorgini","year":"2006","unstructured":"Giorgini F, Guidetti P, Nguyen Q, Bennett SC, Muchowski PJ (2006) A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington\u2019s disease. Nat Genet 37(5):526\u2013531","journal-title":"Nat Genet"},{"issue":"6","key":"1046_CR70","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","volume":"145","author":"D Zwilling","year":"2011","unstructured":"Zwilling D, Huang SY, Sathyasaikumar KV, Notarangelo FM, Guidetti P, Wu HQ, Lee J, Truong J, Andrews-Zwilling Y, Hsieh EW et al (2011) Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell 145(6):863\u2013874","journal-title":"Cell"},{"key":"1046_CR71","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/978-1-4615-0135-0_71","volume":"527","author":"R Pellicciari","year":"2003","unstructured":"Pellicciari R, Amori L, Costantino G, Giordani A, Macchiarulo A, Mattoli L, Pevarello P, Speciale C, Varasi M (2003) Modulation of the kynurenine pathway of tryptophan metabolism in search for neuroprotective agents. Focus on kynurenine-3-hydroxylase. Adv Exp Med Biol 527:621\u2013628","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"1046_CR72","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/jnr.21183","volume":"85","author":"G Ceresoli-Borroni","year":"2007","unstructured":"Ceresoli-Borroni G, Guidetti P, Amori L, Pellicciari R, Schwarcz R (2007) Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications. J Neurosci Res 85(4):845\u2013854","journal-title":"J Neurosci Res"},{"issue":"2","key":"1046_CR73","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1471-4159.2009.05893.x","volume":"109","author":"L Amori","year":"2009","unstructured":"Amori L, Guidetti P, Pellicciari R, Kajii Y, Schwarcz R (2009) On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo. J Neurochem 109(2):316\u2013325","journal-title":"J Neurochem"},{"issue":"26","key":"1046_CR74","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1021\/jm970467t","volume":"40","author":"S R\u00f6ver","year":"1997","unstructured":"R\u00f6ver S, Cesuraa M, Huguenin P, Kettler R, Szente A (1997) Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase. J Med Chem 40(26):4378\u20134385","journal-title":"J Med Chem"},{"issue":"6","key":"1046_CR75","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1046\/j.1471-4159.2002.01090.x","volume":"82","author":"R Carpenedo","year":"2002","unstructured":"Carpenedo R, Meli E, Peruginelli F, Pellegrini-Giampietro DE, Moroni F (2002) Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures. J Neurochem 82(6):1465\u20131471","journal-title":"J Neurochem"},{"issue":"2","key":"1046_CR76","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbr.2007.08.007","volume":"186","author":"L Gr\u00e9goire","year":"2008","unstructured":"Gr\u00e9goire L, Rassoulpour A, Guidetti P, Samadi P, B\u00e9dard PJ, Izzo E, Schwarcz R, Di Paolo T (2008) Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys. Behav Brain Res 186(2):161\u2013167","journal-title":"Behav Brain Res"},{"issue":"1","key":"1046_CR77","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2008.11.055","volume":"159","author":"L Amori","year":"2009","unstructured":"Amori L, Wu HQ, Marinozzi M, Pellicciari R, Guidetti P, Schwarcz R (2009) Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum. Neuroscience 159(1):196\u2013203","journal-title":"Neuroscience"},{"issue":"2","key":"1046_CR78","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4161\/fly.19999","volume":"6","author":"E Green","year":"2012","unstructured":"Green E, Campesan S, Breda C, Sathyasaikumar K, Muchowski P, Schwarcz R, Kyriacou C, Giorgini F (2012) Drosophila eye color mutants as therapeutic tools for Huntington disease. Fly 6(2):117\u2013120","journal-title":"Fly"},{"issue":"37","key":"1046_CR79","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.1073\/pnas.1203083109","volume":"109","author":"AT Goot van der","year":"2012","unstructured":"van der Goot AT, Zhu W, V\u00e1zquez-Manrique RP, Seinstra RI, Dettmer K, Michels H, Farina F, Krijnen J, Melki R, Buijsman RC et al (2012) Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation. Proc Nat Acad Sci U S A 109(37):14912\u201314917","journal-title":"Proc Nat Acad Sci U S A"},{"issue":"229","key":"1046_CR80","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0021-9258(19)63696-3","volume":"2","author":"Y Saito","year":"1957","unstructured":"Saito Y, Hayaishi O, Rothberg S (1957) Studies on oxygenases. Enzymatic formation of 3-hydroxy-L-kynurenine from L-kynurenine. J Biol Chem 2(229):921\u2013934","journal-title":"J Biol Chem"},{"issue":"3","key":"1046_CR81","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-291X(67)90469-X","volume":"29","author":"H Okamoto","year":"1967","unstructured":"Okamoto H, Hayaishi O (1967) Flavin adenine dinucleotide requirement for kynurenine hydroxilase of rat liver mitochondria. Biochem Biophys Res Commun 29(3):394\u2013399","journal-title":"Biochem Biophys Res Commun"},{"key":"1046_CR82","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1021\/ja01593a069","volume":"78","author":"FT Castro De","year":"1956","unstructured":"De Castro FT, Price JM, Brown R (1956) Reduced triphosphopyridinenucleotide requirement for the enzymatic formation of 3-hydroxykynurenine from L-kynurenine. J Am Chem Soc 78:2904\u20132905","journal-title":"J Am Chem Soc"},{"issue":"2","key":"1046_CR83","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0003-2697(92)90432-7","volume":"205","author":"JB Erickson","year":"1992","unstructured":"Erickson JB, Flanagan EM, Russo S, Reinhard JF Jr (1992) A radiometric assay for kynurenine 3-hydroxylase based on the release of 3H2O during hydroxylation of L-[3,5-3H]kynurenine. Anal Biochem 205(2):257\u2013262","journal-title":"Anal Biochem"},{"key":"1046_CR84","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0021-9258(18)70659-5","volume":"28","author":"FT Castro De","year":"1957","unstructured":"De Castro FT, Brown RR, Price JM (1957) The intermediary metabolism of tryptophan by cat and rat tissue preparations. J Biol Chem 28:777\u2013784","journal-title":"J Biol Chem"},{"key":"1046_CR85","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/bj2830633","volume":"283","author":"MP Heyes","year":"1992","unstructured":"Heyes MP, Saito K, Markey SP (1992) Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem J 283:633\u2013635","journal-title":"Biochem J"},{"issue":"2","key":"1046_CR86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/oxfordjournals.jbchem.a021930","volume":"123","author":"T Uemura","year":"1998","unstructured":"Uemura T, Hirai K (1998) L-kynurenine 3-monooxygenase from mitochondrial outer membrane of pig liver: purification, some properties, and monoclonal antibodies directed to the enzyme. J Biochem 123(2):253\u2013262","journal-title":"J Biochem"},{"key":"1046_CR87","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","volume":"527","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ, Smith DG, Smythe GA, Armati PJ, Brew BJ (2003) Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol 527:105\u2013112","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"1046_CR88","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1046\/j.1432-1327.2000.01104.x","volume":"267","author":"J Breton","year":"2000","unstructured":"Breton J, Avanzi N, Magagnin S, Covini N, Magistrelli G, Cozzi L, Isacchi A (2000) Functional characterization and mechanism of action of recombinant human kynurenine 3-hydroxylase. Eur J Biochem 267(4):1092\u20131099","journal-title":"Eur J Biochem"},{"issue":"2","key":"1046_CR89","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pep.2006.07.024","volume":"51","author":"KR Crozier","year":"2007","unstructured":"Crozier KR, Moran GR (2007) Heterologous expression and purification of kynurenine-3-monooxygenase from Pseudomonas fluorescens strain 17400. Protein Expr Purif 51(2):324\u2013333","journal-title":"Protein Expr Purif"},{"issue":"5","key":"1046_CR90","first-page":"1413","volume":"81","author":"Y Nisimoto","year":"1977","unstructured":"Nisimoto Y, Takeuchi F, Shibata Y (1977) Molecular properties of L-kynurenine 3-hydroxylase from rat liver mitochondria. J Biochem 81(5):1413\u20131425","journal-title":"J Biochem"},{"issue":"2\u20133","key":"1046_CR91","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0014-5793(97)00627-3","volume":"410","author":"D Alberati-Giani","year":"1997","unstructured":"Alberati-Giani D, Cesura AM, Broger C, Warren WD, Rover S, Malherbe P (1997) Cloning and functional expression of human kynurenine 3-monooxygenase. FEBS Lett 410(2\u20133):407\u2013412","journal-title":"FEBS Lett"},{"key":"1046_CR92","doi-asserted-by":"crossref","unstructured":"Constantino G, Mattoli L, Moroni F, Natalini B, Pellicciari R (1996) kynurenine 3-hydroxylase and its selective inhibitors. In: Filippini GA (ed) Recent advances in tryptophan research. New York, pp 493\u2013497","DOI":"10.1007\/978-1-4613-0381-7_76"},{"key":"1046_CR93","doi-asserted-by":"crossref","unstructured":"Courtney S, Scheel A (2010) Modulation of the kynurenine pathway for the potential treatment of neurodegenerative diseases. In: Dominguez C (ed) Neurodegenerative Diseases. pp 149\u2013176","DOI":"10.1007\/7355_2010_9"},{"key":"1046_CR94","doi-asserted-by":"crossref","unstructured":"Amaral M, Levy C, Heyes DJ, Lafite P, Outeiro TF, Giorgini F, Leys D, Scrutton NS (2013) Structural basis of kynurenine 3-monooxygenase inhibition. Nature 496(7445):382\u2013385","DOI":"10.1038\/nature12039"},{"issue":"1","key":"1046_CR95","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.abb.2009.11.028","volume":"493","author":"B Palfey","year":"2010","unstructured":"Palfey B, McDonald C (2010) Control of catalysis in flavin-dependent monooxygenases. Arch Biochem Biophys 493(1):26\u201336","journal-title":"Arch Biochem Biophys"},{"issue":"19","key":"1046_CR96","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1021\/bi900149f","volume":"48","author":"M McCulloch","year":"2010","unstructured":"McCulloch M, Mukherjee T, Begley TP, Ealick SE (2010) Structure of the PLP degradative enzyme 2-methyl-3-hydroxypyridine-5-carboxylic acid oxygenase from Mesorhizobium loti MAFF303099 and its mechanistic implications. Biochemistry 48(19):4139\u20134149","journal-title":"Biochemistry"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-013-1046-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-013-1046-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-013-1046-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T21:53:49Z","timestamp":1715291629000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-013-1046-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,1]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1007\/s00109-013-1046-9","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,1]]}}}